Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Pharmaxis Ltd ( (AU:SNT) ) has provided an update.
BVF Partners L.P., along with its associated entities, has ceased to be a substantial holder in Syntara Limited as of June 20, 2025. This change occurred through the on-market sale of a significant number of fully paid ordinary shares, totaling over 104 million shares, which may impact the company’s shareholder structure and market perception.
The most recent analyst rating on (AU:SNT) stock is a Buy with a A$0.12 price target. To see the full list of analyst forecasts on Pharmaxis Ltd stock, see the AU:SNT Stock Forecast page.
More about Pharmaxis Ltd
Average Trading Volume: 10,706,136
Technical Sentiment Signal: Sell
Current Market Cap: A$79.62M
See more data about SNT stock on TipRanks’ Stock Analysis page.